AllianceBernstein’s scPharmaceuticals SCPH Stock Holding History

AllianceBernstein’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-21,010	Closed	-$119K	–	3293
2025 Q3	$119K	Hold	21,010	–	–	﹤0.01%	3164
2025 Q2	$80K	Buy	21,010 +5,800	+38%	+$18K	﹤0.01%	3187
2025 Q1	$40K	Hold	15,210	–	–	﹤0.01%	3155
2024 Q4	$53.8K	Hold	15,210	–	–	﹤0.01%	3180
2024 Q3	$69.4K	Hold	15,210	–	–	﹤0.01%	3166
2024 Q2	$66.2K	Buy	15,210 +4,840	+47%	+$21.3K	﹤0.01%	3167
2024 Q1	$52.1K	Hold	10,370	–	–	﹤0.01%	3083
2023 Q4	$65K	Hold	10,370	–	–	﹤0.01%	3109
2023 Q3	$73.8K	Buy	+10,370	New	+$81.7K	﹤0.01%	3102

AllianceBernstein's SCPH Position: Q4 2025 in Review

AllianceBernstein sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 21,010 shares — an estimated $119K sold.

AllianceBernstein first reported a position in SCPH in Q3 2023 and held it in 9 quarters. The position peaked at $119K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

AllianceBernstein reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
AllianceBernstein sold 21,010 scPharmaceuticals shares in Q4 2025, an estimated $119K.
AllianceBernstein first reported a position in scPharmaceuticals in Q3 2023 and held it in 9 quarters.
AllianceBernstein's scPharmaceuticals position peaked at $119K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on AllianceBernstein's 13F filing for Q4 2025, filed 17 Feb 2026.